Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Breast Cancer Res Treat. 2019 Feb 6;175(1):247–259. doi: 10.1007/s10549-019-05156-5

Figure 2. Tumor Immune Dysfunction and Exclusion (TIDE) scores by patient race across all tumor subtypes.

Figure 2.

The mean TIDE, IFN-gamma (“IFNG”), T-cell dysfunction (“Dysfunction”), and T-cell exclusion (“Exclusion”) scores are displayed for each race cohort, with error bars representing standard error of the mean. All tumor subtypes are included. The means of AA scores are in dark grey; the means of Caucasian scores are in light grey. **Student’s t-test p=0.014.